P. Kaufman

466 total citations
10 papers, 367 citations indexed

About

P. Kaufman is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, P. Kaufman has authored 10 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in P. Kaufman's work include Cancer Treatment and Pharmacology (4 papers), HER2/EGFR in Cancer Research (3 papers) and Advanced Breast Cancer Therapies (2 papers). P. Kaufman is often cited by papers focused on Cancer Treatment and Pharmacology (4 papers), HER2/EGFR in Cancer Research (3 papers) and Advanced Breast Cancer Therapies (2 papers). P. Kaufman collaborates with scholars based in United States, Australia and Italy. P. Kaufman's co-authors include J. N. Ingle, N E Davidson, Robert B. Jenkins, Brittany L. Murphy, Patrick C. Roche, Silvana Martino, EA Perez, VJ Suman, Thomas J. Doyle and Mark DeMario and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and JNCI Journal of the National Cancer Institute.

In The Last Decade

P. Kaufman

10 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P. Kaufman United States	5	317	213	113	112	31	10	367
Fanglei You United States	6	197 0.6×	94 0.4×	114 1.0×	88 0.8×	13 0.4×	9	302
Matthew Cunningham United Kingdom	8	231 0.7×	114 0.5×	115 1.0×	43 0.4×	20 0.6×	13	340
Cammie R. Sutton United States	6	289 0.9×	164 0.8×	251 2.2×	59 0.5×	69 2.2×	9	421
Neil Atkey United Kingdom	10	186 0.6×	83 0.4×	97 0.9×	69 0.6×	25 0.8×	14	295
Rochelle Strenger United States	6	370 1.2×	131 0.6×	46 0.4×	164 1.5×	11 0.4×	19	414
VJ Suman United States	6	338 1.1×	220 1.0×	130 1.2×	175 1.6×	28 0.9×	15	439
Jean-Yves Leroy Belgium	6	396 1.2×	104 0.5×	223 2.0×	158 1.4×	18 0.6×	11	465
Jeff Sperinde United States	15	495 1.6×	337 1.6×	193 1.7×	88 0.8×	40 1.3×	35	611
Sietske B.M. Gaykema Netherlands	8	168 0.5×	233 1.1×	91 0.8×	57 0.5×	12 0.4×	8	356
F. Barros United Kingdom	8	159 0.5×	72 0.3×	128 1.1×	128 1.1×	34 1.1×	9	312

Countries citing papers authored by P. Kaufman

Since Specialization

Citations

This map shows the geographic impact of P. Kaufman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Kaufman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Kaufman more than expected).

Fields of papers citing papers by P. Kaufman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Kaufman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Kaufman. The network helps show where P. Kaufman may publish in the future.

Co-authorship network of co-authors of P. Kaufman

This figure shows the co-authorship network connecting the top 25 collaborators of P. Kaufman. A scholar is included among the top collaborators of P. Kaufman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Kaufman. P. Kaufman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Kaufman, P., et al.. (2024). Preventing chemotherapy-induced diarrhea and microbiota imbalances with prebiotics and probiotics in breast cancer treatment: A case report. SHILAP Revista de lepidopterología. 1(1). 2 indexed citations

Mehta, Rita S., et al.. (2011). OT2-05-02: ACRIN 6691 Monitoring and Predicting Breast Cancer Neoadjuvant Chemotherapy Response Using Diffuse Optical Spectroscopic Imaging (DOSI).. Cancer Research. 71(24_Supplement). OT2–5. 4 indexed citations

Reinholz, Monica M., Xochiquetzal J. Geiger, Ann E. McCullough, et al.. (2011). Effect of IGF1R protein expression on benefit to adjuvant trastuzumab in early-stage HER2+ breast cancer in NCCTG N9831 trial.. Journal of Clinical Oncology. 29(15_suppl). 10503–10503. 7 indexed citations

Perez, Edith A., Monica M. Reinholz, Xochiquetzal J. Geiger, et al.. (2011). Effect of PTEN protein expression on benefit to adjuvant trastuzumab in early-stage HER2+ breast cancer in NCCTG adjuvant trial N9831.. Journal of Clinical Oncology. 29(15_suppl). 10504–10504. 7 indexed citations

Kaufman, P., et al.. (2009). 5029 Motesanib (AMG 706) in combination with paclitaxel or docetaxel: phase 1b study in patients with locally recurrent, unresectable or metastatic breast cancer. European Journal of Cancer Supplements. 7(2). 269–269. 1 indexed citations

Moreno‐Aspitia, Alvaro, Amylou C. Dueck, Wilma L. Lingle, et al.. (2008). Serum HER2 (sHER2) levels in early-stage HER2 neu (+) breast cancer (HER2+BC): Results from the NCCTG adjuvant Intergroup trial N9831. Journal of Clinical Oncology. 26(15_suppl). 529–529. 2 indexed citations

Perez, EA, et al.. (2006). Radiotherapy concurrent with trastuzumab is well tolerated in the adjuvant treatment of women with HER2-positive breast cancer: cardiac safety data from the NCCTG N9831 study. European Journal of Cancer Supplements. 4(2). 113–113. 1 indexed citations

Overmoyer, Beth, Stanley E. Waintraub, P. Kaufman, et al.. (2005). Phase II trial of KOS-862 (epothilone D) in anthracycline and taxane pretreated metastatic breast cancer. Journal of Clinical Oncology. 23(16_suppl). 778–778. 17 indexed citations

Diéras, V., Vicente Valero, Steven Limentani, et al.. (2005). Multicenter, non-randomized phase II study with RPR109881 in taxane-exposed metastatic breast cancer (MBC) patients (pts): Final results. Journal of Clinical Oncology. 23(16_suppl). 565–565. 13 indexed citations

10.

Roche, Patrick C., VJ Suman, Robert B. Jenkins, et al.. (2002). Concordance Between Local and Central Laboratory HER2 Testing in the Breast Intergroup Trial N9831. JNCI Journal of the National Cancer Institute. 94(11). 855–857. 313 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact